OLO. I. Loginova

O. I. Loginova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


O. I. Loginova has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pheochromocytoma in Neurofibromatosis Type 1

    by D. V. Rebrova, O. I. Loginova, S. L. Nepomnyashchaya, A. R. Bakhtiyarova, V. F. Rusakov, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, Sh. Sh. Shikhmagomedov, E. N. Imyanitov, et al.

    Neurofibromatosis type 1 is a hereditary disease with a wide variability of clinical manifestations, from the almost complete absence of typical symptoms to a multisystem lesion of the body. One of the possible clinical manifestations of this pathology is a pheochromocytoma — a tumor of the adrenal gland with the possible development of considerable cardiovascular complications. The article describes four cases of patients with pheochromocytoma as part of familial neurofibromatosis type 1, differing in clinical course from asymptomatic form to vivid paroxysmal manifestations. At the same time, the presence and degree of arterial hypertension did not correlate with the level of metanephrines and the size of the pheochromocytoma. 3 out of 4 patients have a hereditary history of neurofibromatosis type 1. In 1 out of 4 cases, simultaneous bilateral damage to the adrenal glands was noted, while the radiation characteristics of pheochromocytomas, both with computed tomography and CT/PET with 18-FDG, differed from the "classic" ones. An objective examination with the identification of "erased" signs of neurofibromatosis type 1 made it possible to establish the diagnosis of bilateral pheochromocytoma even with questionable laboratory and imaging data. Knowledge of clinical manifestations, timely diagnosis of neurofibromatosis type 1, comprehensive treatment and subsequent regular monitoring of patients, as well as examination of blood relatives can significantly improve prognosis and survival.


  • Rhabdomyolysis as a dangerous complication of primary hyperaldosteronism

    by D. V. Rebrova, S. L. Nepomnyashchaya, V. F. Rusakov, E. A. Fedorov, L. M. Krasnov, A. R. Bakhtiyarova, O. I. Loginova, R. A. Chernikov, I. V. Sleptsov

    Rhabdomyolysis is a rare, dangerous complication of primary hyperaldosteronism (PHA) induced by hypokalemia. PHA is underdiagnosed because it does not have a specific, easily identifiable feature and clinicians can be poorly aware of the disease. Prompt diagnosis of PHA and the use of targeted treatment strategies mitigate aldosterone-specific target organ damage, such as rhabdomyolysis. Progressive muscle weakness, as the main symptom of the development of muscle damage, is a reason to monitor electrolyte balance. We present a detailed description of two cases of rhabdomyolysis with hypokalemia. Patient 1, 45 y.o., with an increase in blood pressure (BP) to 220/120 mmHg, which could not be corrected against the background of 3-component antihypertensive therapy, with complaints of headaches, dizziness, sweating, severe muscle weakness of the extremities, muscle pain, was acutely admitted to the hospital, where creatine phosphokinase (CPK) 17204 IU/l (up to 145), CPKMB 205 IU/L (up to 24), AST 889 U/L (up to 35), ALT 232 U/L (up to 40), blood potassium 2.0 mmol/L (3.3–5.5). Neurologist, rheumatologist excluded pathology. Aldosteroma of the right adrenal gland was detected with normalization of BP and potassium levels after adrenalectomy. Patient 2, 55 y.o., with an increased BP of 200/110 mmHg, general and muscular weakness, severe pain in the muscles and joints of the extremities, shortness of breath during physical exertion, heart arrhythmia, was observed for 6 years by a cardiologist, neurologist, rheumatologist, with repeated hospitalizations, including for about rhabdomyolysis. Despite recurrent hypokalemia, the adrenal gland examination was performed only after consultation with an endocrinologist due to loss of consciousness in case of hypoglycemia. The examination revealed primary hyperparathyroidism, bilateral PHA, non-toxic nodular goiter, pituitary microadenoma. Hypoglycemia was not achieved in the 72-hour fasting trial. Multiple endocrine neoplasia type 1 syndrome has been established clinically. In the available literature in Russian and in English, we have found the description of less than 40 similar case reports. A detailed description of those cases is also provided.

  • Open Access

    Adrenocortical Cancer. Results of Examination of Patients at the Clinic of High Medical Technologies

    by Дина Владимировна Реброва, Илья Валерьевич Слепцов, Роман Анатольевич Черников, Игорь Константинович Чинчук, Владимир Федорович Русаков, Леонид Михайлович Краснов, Елисей Александрович Федоров, Арсений Андреевич Семенов, Татьяна Вячеславовна Савельева, Ольга Ивановна Логинова, et al.

    Materials and Methods. The article describes the results of the examination of 76 patients with adrenocortical cancer (ACC), who have undergone surgery in the in-patient facility of the N.I. Pirogov Clinic of High Medical Technologies of St. Petersburg State University. ACC was diagnosed from 2009 to 2020. Patient demographic data, baseline disease characteristics, tumor hormonal activity, and computed tomography (CT) data were described. Results. Overall, the data obtained were consistent with the international literature with respect to age at onset of the disease (median age 45 years), the ratio of females to males (3:1), and the incidence of hypercortisolism (48.8 %). It was found that the combination of radiographic density ≤ 20 HU and mass size less than 4 cm does not exclude all cases of ACC. According to the findings 2 (3.3 %) of 65 patients would not be diagnosed if the above criteria had been used. Within the CT data analysis, about one-third of patients showed no increase in the standard thresholds for absolute and relative percentage washout (RPW) that defines malignancy. The results analysis revealed that the subgroup of patients with Cushing syndrome had a statistically significant increase in contrast washout rates. Conclusion. Overall, the findings in ACC patients in the studied population are consistent with the literature data. The study results suggest that the diagnostic value of contrast washout parameters for differential diagnosis of ACC is limited, especially in patients with small tumors and with Cushing syndrome. According to the data obtained, the most reliable criterion for excluding ACR is native tumor radiodensity < 10 HU; the use of this criterion made it possible to exclude all cases of ACC. Материалы и методы. В настоящей статье приведено описание результатов обследования 76 пациентов с адренокортикальным раком (АКР), прооперированных в стационаре Петербургского государственного университета. Диагноз АКР был установлен с 2009 по 2020 гг. Описаны демографические характеристики пациентов, основные характеристики заболевания, гормональная активность опухоли, данные компьютерной томографии (КТ). Результаты. В целом получены данные, согласующиеся с международной литературой, в отношении возраста при дебюте заболевания (медиана возраста — 45 лет), соотношения лиц женского и мужского пола (3:1), частоты гиперкортизолизма (48,8 %). Обнаружено, что сочетание рентгенологической плотности ≤ 20 HU и размера новообразования менее 4 см не исключает все случаи АКР, согласно полученным данным, у 2 (3,3 %) из 65 пациентов при использовании указанных критериев заболевание было бы пропущено. В рамках анализа данных КТ примерно у трети пациентов не обнаружено повышения стандартных порогов абсолютного и относительного процентов вымывания контраста для определения злокачественности опухоли. При анализе результатов было обнаружено, что в подгруппе пациентов с манифестным синдромом Иценко — Кушинга, при сравнении с остальными, имеет место статистически значимое повышение показателей вымывания контраста. Заключение. В целом полученные данные у пациентов с АКР в исследованной популяции согласуются с литературными. Результаты исследования свидетельствуют о том, что диагностическая ценность определения показателей вымывания контраста для дифференциальной диагностики АКР ограничена, особенно при небольших размерах новообразования и при синдроме Иценко - Кушинга. Согласно полученным данным, наиболее надежным критерием исключения АКР является нативная рентгенологическая плотность < 10 HU, использование этого критерия позволило исключить АКР во всех случаях.

  • Open Access

    Case reports of diagnosis and treatment of adrenal tumors complicated by rupture and formation of retroperitoneal hematoma

    by S. L. Nepomnyashchaya, E. A. Fedorov, L. M. Krasnov, D. V. Rebrova, Y. V. Semiletova, I. A. Pavlikova, A. R. Bakhtiyarova, V. N. Danilin, V. V. Dmitrichenko, O. V. Kuleshov, et al.

    This article presents different variants of the clinical course of complications of adrenal tumors with rupture and formation of retroperitoneal hematomas, depending on the morphological characteristics of the neoplasms. The first clinical case described a 38-year-old patient with adrenocortical carcinoma of the left adrenal gland up to 8 cm in size, complicated by rupture with the formation of a retroperitoneal hematoma with a volume of 2800 cm3 , simulating a giant extraorgan retroperitoneal tumor with anemia and cachexia. After surgical treatment and stabilization of the condition, the patient is referred for chemotherapy with a positive outcome. The second case is about a 21-year-old patient with undiagnosed pheochromocytoma, who had a tumor rupture with hemorrhage and the development of acute symptoms against the background of the start of antihypertensive therapy. After the retroperitoneoscopic adrenalectomy, the condition stabilized. The third case is about the experience of observing a 45-year-old patient with myelolipoma up to 6.4 cm, complicated by a previously suffered retroperitoneal hematoma, in whom surgical treatment was not performed due to the presence of end-stage chronic kidney disease and stable tumor condition.

  • Open Access

    Metastatic risk factors in pheochromocytoma/paraganglioma

    by D. V. Rebrova, O. I. Loginova, S. L. Vorobyev, N. V. Vorokhobina, E. S. Kozorezova, F. A. Indeykin, T. V. Savelyeva, I. V. Sleptsov, R. A. Chernikov, E. A. Fedorov, et al.

    Currently, all pheochromocytoma/paraganglioma (PPGLs) are considered malignant due to metastatic potential. Consequently, PPGLs are divided into «metastatic» and «non-metastatic». Metastatic PPGLs can be with synchronous metastasis (metastases appear simultaneously with the identified primary tumor) or metachronous (metastases develop after removal of the primary tumor). The term metastatic PPGLs is not used in the presence of tumor invasion into surrounding organs and tissues, without the presence of distant metastases of lymphogenic or hematogenic origin. It is generally believed that about 10% of pheochromocytomas and about 40% of sympathetic paragangliomas have metastatic potential. On average, the prevalence of PPGLs with the presence of metastases is 15–20%. Risk factors for metastatic PPGLs are widely discussed in the literature, the most significant of which are groups of clinical, morphological and genetic characteristics. The review presents a discussion of such risk factors for metastatic PPGLs as age, localization and type of hormonal secretion of the tumor, the size and growth pattern of the adrenal lesion, the presence of necrosis and invasion into the vessels, the tumor capsule surrounding adipose tissue, high cellular and mitotic activity, Ki-67 index, expression of chromogranin B and S100 protein, the presence of genetic mutations of three main clusters (pseudohypoxia, kinase signaling and Wnt signaling).Over the past two decades, a number of authors have proposed various predictor factors and scales for assessing a probability of metastatic PPGLs. The review contains detailed description and comparison of sensitivity and specificity of such predictor scales as PASS, GAPP, M-GAPP, ASES and COPPS.


  • Open Access

    Diagnostic value of ct in examination of patients with adrenal cancer

    by V. F. Rusakov, I. E. Shcherbakov, I. K. Chinchuk, T. V. Savelyeva, D. V. Rebrova, O. I. Loginova, T. S. Pridvizhkina, R. A. Chernikov, L. M. Krasnov, J. N. Fedotov, et al.

    BACKGROUND: In most cases adrenal tumours are detected by accident while performing medical imaging tests for other diseases. These findings are treated as adrenal incidentaloma. Prevalence of incidentalomas detected on CT scans is up to 4%. According to different authors, 4–12% of all adrenal tumours are adrenocortical carcinomas. As for today, the most significant medical imaging technique is CT scan with bolus IV injection of contrast agent and assessment of tumour’s density. The analysis of the results of CT imaging in 67 patients with ACC was carried out according to a single protocol. The main signs characteristic of this disease are described. It is very important to evaluate typical signs of ACC on CT scans for risk assessment of ACC before surgical treatment. If malignant tumour is suspected during preoperative examination, it is extremely important to choose the right surgical treatment strategy.AIM: To evaluate the significance of CT as the main method of preoperative diagnosis in patients with malignant tumors of the adrenal cortex. Studying CT semiotics of adrenocortical cancer in a large group of patients using a single standard imaging protocol. Find the main radiological symptoms characteristic of adrenocortical cancerMATERIALS AND METHODS: Here are the results of retrospective study of CT scans performed on 67 patients with adrenocortical carcinoma who received treatment in the Department of Endocrine Surgery of Saint-Petersburg State University N.I. Pirogov Clinic of High Medical Technologies during 2012–2020. The diagnostic significance of CT in patients with ACC was assessed.RESULTS: The most common features of ACC: tumour heterogeneity (84.3%), tumour’s size 3–9 cm (75%), signs of invasion into surrounding structures (10%), pre-contrast density above +30 HU (75%), absolute contrast washout less than 60% (68.8%), relative contrast washout less than 40% (64.6%)CONCLUSION: CT scan with IV contrast was not able to show any definitive pathognomonic signs of ACC. Nevertheless, CT scan should be performed in all patients with suspected (or confirmed using other medical imaging technique) adrenal tumour according to standard protocol. Bolus injection of contrast agent should be performed in all patients with tumour’s pre-contrast density above +5 HU.